The CNRS, a major actor in Deeptech, once again present at VivaTech

Institutional matters

• Technology transfer for research is a CNRS mission. With nearly 100 start-ups created per year, and more than 6,000 families of active patents, 1,300 active licenses, and 160 joint laboratories with companies, the CNRS is a major actor in Deeptech in France.

• Scientists, start-ups, and technologies from laboratories under CNRS supervisory authority will be present at the 2021 edition of VivaTech.

For its second participation in VivaTech—the European global tech gathering to be held between 16 and 19 June 2021 in Paris—the CNRS will present a wide sample of its Deeptech know-how! From biotechs and greentechs to quantum technologies and sport, scientists and start-ups from CNRS laboratories and its partners will present the technologies of the future.


Learn more at the CNRS stand: embedded biosensors for diagnosis and remote patient monitoring, solutions to increase the lifespan of photovoltaic modules, technology for reducing noise pollution, and a bicycle that stimulates the muscles of individuals with motor disability.

This year the CNRS will honour quantum technologies and hydrogen in particular. At VivaTech you will discover the most recent achievements in quantum processors and hydrogen fuel cells. Complete programming to follow!

With over 1,500 start-ups from laboratories under its supervisory authority, the CNRS is among the major actors in Deeptech in France. A typical profile of these start-ups is a company that, in its third year of existence, employs twenty people and generates revenues of 3 million euros across all scientific domains.



Alexiane Agullo
CNRS press officer